Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiko Kurikawa

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nature|October 14, 2021
Structural basis of cytokine-mediated activation of ALK family receptorsSteven De Munck, Mathias Provost, Michiko Kurikawa, et al.
Biotechniques|June 28, 2025
Dual compartment utility of BRET-based biosensors for PPP2R5A/B56α, a cancer-associated B regulatory subunit of PP2AHirofumi Yamauchi, Atsuro Oishi, Masahiko Ajiro, et al.
Breast Cancer (Tokyo, Japan)|January 3, 2021
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)Takamichi Yokoe, Sasagu Kurozumi, Kazuki Nozawa, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nature|October 14, 2021
Structural basis of cytokine-mediated activation of ALK family receptorsSteven De Munck, Mathias Provost, Michiko Kurikawa, et al.
Biotechniques|June 28, 2025
Dual compartment utility of BRET-based biosensors for PPP2R5A/B56α, a cancer-associated B regulatory subunit of PP2AHirofumi Yamauchi, Atsuro Oishi, Masahiko Ajiro, et al.
Breast Cancer (Tokyo, Japan)|January 3, 2021
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)Takamichi Yokoe, Sasagu Kurozumi, Kazuki Nozawa, et al.
Pageof 1